ProShares UltraShort NASDAQ Biotechnology closed at $11.15 on Sep 28, down 0.95%, 67.1% below its 52-week closing high. Volume of 10.7K shares was 1.64× its 20-day average (above normal).
Split-adjusted performance: +4.0% over one month, -43.2% over six months, -60.4% over one year.
Short interest was 5.6K shares at the Sep 15 settlement, down 4.1% from the prior report (1.0 days to cover).
No recent articles focused on ProShares UltraShort NASDAQ Biotechnology.
Quick answers
What is BIS's market cap?
$1.85M, based on the Sep 28 close of $11.15.
Does ProShares UltraShort NASDAQ Biotechnology pay a dividend?
Yes. The latest regular dividend was $0.1389 per share (ex-date Sep 23), an annualised yield of 4.98%.
Sources: Massive / Polygon daily aggregates (split-adjusted) · SEC filings via Massive · FINRA settlements via Massive · Financial Modeling Prep. Figures are dated where shown; research is informational, not investment advice. Methodology